Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 26
Judge Issues Rulings on Pre-Trial Motions for Next Vioxx MDL Case
Texas Judge Orders $27.35 Million Payment to Plaintiffs in First Vioxx Trial
Bextra/Celebrex MDL Parties Dispute Video Deposition Procedures
Journal's Vioxx Article Correction Suggests Earlier Cardiovascular Risk
Merck Says Dr. David Graham's Testimony Unreliable, Inadmissible
Court Affirms Dismissal of State Class Action Seeking Vioxx Refund
Single Case Selected for California's First Vioxx Trial
Study Shows NSAIDs Increase Death Risk for Heart Attack Survivors
